Linfoma no Hodgkin en adultos: Tratamiento (PDQ®) - National ...

Linfoma no Hodgkin en adultos: Tratamiento (PDQ®) - National Cancer Institute
53. Press OW, Unger JM, Braziel RM, et al.: Phase II trial of CHOP chemotherapy followed by
tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: fiveyear
follow-up of Southwest Oncology Group Protocol S9911. J Clin Oncol 24 (25): 4143-9, 2006.
[PUBMED Abstract]
54. Morschhauser F, Radford J, Van Hoof A, et al.: Phase III trial of consolidation therapy with yttrium-90ibritumomab
tiuxetan compared with no additional therapy after first remission in advanced follicular
lymphoma. J Clin Oncol 26 (32): 5156-64, 2008. [PUBMED Abstract]
55. Apostolidis J, Gupta RK, Grenzelias D, et al.: High-dose therapy with autologous bone marrow support as
consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up. J Clin
Oncol 18 (3): 527-36, 2000. [PUBMED Abstract]
56. van Besien K, Sobocinski KA, Rowlings PA, et al.: Allogeneic bone marrow transplantation for low-grade
lymphoma. Blood 92 (5): 1832-6, 1998. [PUBMED Abstract]
57. Gopal AK, Gooley TA, Maloney DG, et al.: High-dose radioimmunotherapy versus conventional high-dose
therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin
lymphoma: a multivariable cohort analysis. Blood 102 (7): 2351-7, 2003. [PUBMED Abstract]
58. van Besien K, Loberiza FR Jr, Bajorunaite R, et al.: Comparison of autologous and allogeneic
hematopoietic stem cell transplantation for follicular lymphoma. Blood 102 (10): 3521-9, 2003. [PUBMED
Abstract]
59. Schouten HC, Qian W, Kvaloy S, et al.: High-dose therapy improves progression-free survival and survival
in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J Clin
Oncol 21 (21): 3918-27, 2003. [PUBMED Abstract]
60. Deconinck E, Foussard C, Milpied N, et al.: High-dose therapy followed by autologous purged stem-cell
transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a
randomized multicenter study by GOELAMS. Blood 105 (10): 3817-23, 2005. [PUBMED Abstract]
61. Sebban C, Mounier N, Brousse N, et al.: Standard chemotherapy with interferon compared with CHOP
followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced
follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte
(GELA). Blood 108 (8): 2540-4, 2006. [PUBMED Abstract]
62. Lenz G, Dreyling M, Schiegnitz E, et al.: Myeloablative radiochemotherapy followed by autologous stem
cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a
prospective, randomized trial of the German Low-Grade Lymphoma Study Group. Blood 104 (9): 2667-74,
2004. [PUBMED Abstract]
63. Rohatiner AZ, Nadler L, Davies AJ, et al.: Myeloablative therapy with autologous bone marrow
transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
J Clin Oncol 25 (18): 2554-9, 2007. [PUBMED Abstract]
64. Gopal AK, Rajendran JG, Gooley TA, et al.: High-dose [131I]tositumomab (anti-CD20)
radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old
with relapsed or refractory B-cell lymphoma. J Clin Oncol 25 (11): 1396-402, 2007. [PUBMED Abstract]
65. Gyan E, Foussard C, Bertrand P, et al.: High-dose therapy followed by autologous purged stem cell
transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a
randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.
Blood 113 (5): 995-1001, 2009. [PUBMED Abstract]
66. Bendandi M, Gocke CD, Kobrin CB, et al.: Complete molecular remissions induced by patient-specific
vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 5 (10): 1171-
7, 1999. [PUBMED Abstract]
67. Neelapu SS, Gause BL, Nikcevich DA, et al.: Phase III randomized trial of patient-specific vaccination for
previously untreated patients with follicular lymphoma in first complete remission: protocol summary and
interim report. Clin Lymphoma 6 (1): 61-4, 2005. [PUBMED Abstract]
68. Inogès S, Rodrìguez-Calvillo M, Zabalegui N, et al.: Clinical benefit associated with idiotypic vaccination
in patients with follicular lymphoma. J Natl Cancer Inst 98 (18): 1292-301, 2006. [PUBMED Abstract]
69. Ha CS, Kong JS, Tucker SL, et al.: Central lymphatic irradiation for stage I-III follicular lymphoma: report
file:///Users/mauriciolema/Documents/MLMGuias_09_LinfomaNoHodgkin.webarchive
29/09/11 6:15
Página 40 de 61